116 related articles for article (PubMed ID: 38069582)
1. Ultrasound Radiomics Features to Identify Patients With Triple-Negative Breast Cancer: A Retrospective, Single-Center Study.
Cai L; Sidey-Gibbons C; Nees J; Riedel F; Schaefgen B; Togawa R; Killinger K; Heil J; Pfob A; Golatta M
J Ultrasound Med; 2024 Mar; 43(3):467-478. PubMed ID: 38069582
[TBL] [Abstract][Full Text] [Related]
2. Can multi-modal radiomics using pretreatment ultrasound and tomosynthesis predict response to neoadjuvant systemic treatment in breast cancer?
Cai L; Sidey-Gibbons C; Nees J; Riedel F; Schäfgen B; Togawa R; Killinger K; Heil J; Pfob A; Golatta M
Eur Radiol; 2024 Apr; 34(4):2560-2573. PubMed ID: 37707548
[TBL] [Abstract][Full Text] [Related]
3. BI-RADS Ultrasound Lexicon Descriptors and Stromal Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer.
Candelaria RP; Spak DA; Rauch GM; Huo L; Bassett RL; Santiago L; Scoggins ME; Guirguis MS; Patel MM; Whitman GJ; Moulder SL; Thompson AM; Ravenberg EE; White JB; Abuhadra NK; Valero V; Litton J; Adrada BE; Yang WT
Acad Radiol; 2022 Jan; 29 Suppl 1(Suppl 1):S35-S41. PubMed ID: 34272161
[TBL] [Abstract][Full Text] [Related]
4. Radiomics features on ultrasound imaging for the prediction of disease-free survival in triple negative breast cancer: a multi-institutional study.
Yu F; Hang J; Deng J; Yang B; Wang J; Ye X; Liu Y
Br J Radiol; 2021 Oct; 94(1126):20210188. PubMed ID: 34478336
[TBL] [Abstract][Full Text] [Related]
5. Prediction for pathological and immunohistochemical characteristics of triple-negative invasive breast carcinomas: the performance comparison between quantitative and qualitative sonographic feature analysis.
Li JW; Cao YC; Zhao ZJ; Shi ZT; Duan XQ; Chang C; Chen JG
Eur Radiol; 2022 Mar; 32(3):1590-1600. PubMed ID: 34519862
[TBL] [Abstract][Full Text] [Related]
6. Radiomics of US texture features in differential diagnosis between triple-negative breast cancer and fibroadenoma.
Lee SE; Han K; Kwak JY; Lee E; Kim EK
Sci Rep; 2018 Sep; 8(1):13546. PubMed ID: 30202040
[TBL] [Abstract][Full Text] [Related]
7. A pilot study of radiomics technology based on X-ray mammography in patients with triple-negative breast cancer.
Zhang HX; Sun ZQ; Cheng YG; Mao GQ
J Xray Sci Technol; 2019; 27(3):485-492. PubMed ID: 31081797
[TBL] [Abstract][Full Text] [Related]
8. Utilizing grayscale ultrasound-based radiomics nomogram for preoperative identification of triple negative breast cancer.
Xu M; Zeng S; Li F; Liu G
Radiol Med; 2024 Jan; 129(1):29-37. PubMed ID: 37919521
[TBL] [Abstract][Full Text] [Related]
9. A Radiomics Model Based on Synthetic MRI Acquisition for Predicting Neoadjuvant Systemic Treatment Response in Triple-Negative Breast Cancer.
Hwang KP; Elshafeey NA; Kotrotsou A; Chen H; Son JB; Boge M; Mohamed RM; Abdelhafez AH; Adrada BE; Panthi B; Sun J; Musall BC; Zhang S; Candelaria RP; White JB; Ravenberg EE; Tripathy D; Yam C; Litton JK; Huo L; Thompson AM; Wei P; Yang WT; Pagel MD; Ma J; Rauch GM
Radiol Imaging Cancer; 2023 Jul; 5(4):e230009. PubMed ID: 37505106
[TBL] [Abstract][Full Text] [Related]
10. A model combining pretreatment MRI radiomic features and tumor-infiltrating lymphocytes to predict response to neoadjuvant systemic therapy in triple-negative breast cancer.
Jimenez JE; Abdelhafez A; Mittendorf EA; Elshafeey N; Yung JP; Litton JK; Adrada BE; Candelaria RP; White J; Thompson AM; Huo L; Wei P; Tripathy D; Valero V; Yam C; Hazle JD; Moulder SL; Yang WT; Rauch GM
Eur J Radiol; 2022 Apr; 149():110220. PubMed ID: 35193025
[TBL] [Abstract][Full Text] [Related]
11. Radiomics features based on automatic segmented MRI images: Prognostic biomarkers for triple-negative breast cancer treated with neoadjuvant chemotherapy.
Ma M; Gan L; Liu Y; Jiang Y; Xin L; Liu Y; Qin N; Cheng Y; Liu Q; Xu L; Zhang Y; Wang X; Zhang X; Ye J; Wang X
Eur J Radiol; 2022 Jan; 146():110095. PubMed ID: 34890936
[TBL] [Abstract][Full Text] [Related]
12. Magnetic resonance imaging radiomics predicts preoperative axillary lymph node metastasis to support surgical decisions and is associated with tumor microenvironment in invasive breast cancer: A machine learning, multicenter study.
Yu Y; He Z; Ouyang J; Tan Y; Chen Y; Gu Y; Mao L; Ren W; Wang J; Lin L; Wu Z; Liu J; Ou Q; Hu Q; Li A; Chen K; Li C; Lu N; Li X; Su F; Liu Q; Xie C; Yao H
EBioMedicine; 2021 Jul; 69():103460. PubMed ID: 34233259
[TBL] [Abstract][Full Text] [Related]
13. Early ultrasound evaluation identifies excellent responders to neoadjuvant systemic therapy among patients with triple-negative breast cancer.
Adrada BE; Candelaria R; Moulder S; Thompson A; Wei P; Whitman GJ; Valero V; Litton JK; Santiago L; Scoggins ME; Moseley TW; White JB; Ravenberg EE; Yang WT; Rauch GM
Cancer; 2021 Aug; 127(16):2880-2887. PubMed ID: 33878210
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis of triple negative breast cancer based on radiomics signatures extracted from preoperative contrast-enhanced chest computed tomography.
Feng Q; Hu Q; Liu Y; Yang T; Yin Z
BMC Cancer; 2020 Jun; 20(1):579. PubMed ID: 32571245
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of peritumoral vascular and intratumoral radiomics to predict pathologic complete responses to neoadjuvant chemotherapy in patients with triple-negative breast cancer.
Xie T; Gong J; Zhao Q; Wu C; Wu S; Peng W; Gu Y
BMC Med Imaging; 2024 Jun; 24(1):136. PubMed ID: 38844842
[TBL] [Abstract][Full Text] [Related]
16. Association of machine learning ultrasound radiomics and disease outcome in triple negative breast cancer.
Wang H; Li X; Yuan Y; Tong Y; Zhu S; Huang R; Shen K; Guo Y; Wang Y; Chen X
Am J Cancer Res; 2022; 12(1):152-164. PubMed ID: 35141010
[TBL] [Abstract][Full Text] [Related]
17. Predicting Breast Cancer in Breast Imaging Reporting and Data System (BI-RADS) Ultrasound Category 4 or 5 Lesions: A Nomogram Combining Radiomics and BI-RADS.
Luo WQ; Huang QX; Huang XW; Hu HT; Zeng FQ; Wang W
Sci Rep; 2019 Aug; 9(1):11921. PubMed ID: 31417138
[TBL] [Abstract][Full Text] [Related]
18. MRI Radiomics for Assessment of Molecular Subtype, Pathological Complete Response, and Residual Cancer Burden in Breast Cancer Patients Treated With Neoadjuvant Chemotherapy.
Choudhery S; Gomez-Cardona D; Favazza CP; Hoskin TL; Haddad TC; Goetz MP; Boughey JC
Acad Radiol; 2022 Jan; 29 Suppl 1(Suppl 1):S145-S154. PubMed ID: 33160859
[TBL] [Abstract][Full Text] [Related]
19. Quantitative Apparent Diffusion Coefficients From Peritumoral Regions as Early Predictors of Response to Neoadjuvant Systemic Therapy in Triple-Negative Breast Cancer.
Musall BC; Adrada BE; Candelaria RP; Mohamed RMM; Abdelhafez AH; Son JB; Sun J; Santiago L; Whitman GJ; Moseley TW; Scoggins ME; Mahmoud HS; White JB; Hwang KP; Elshafeey NA; Boge M; Zhang S; Litton JK; Valero V; Tripathy D; Thompson AM; Yam C; Wei P; Moulder SL; Pagel MD; Yang WT; Ma J; Rauch GM
J Magn Reson Imaging; 2022 Dec; 56(6):1901-1909. PubMed ID: 35499264
[TBL] [Abstract][Full Text] [Related]
20. Application of mammography-based radiomics signature for preoperative prediction of triple-negative breast cancer.
Ge S; Yixing Y; Jia D; Ling Y
BMC Med Imaging; 2022 Sep; 22(1):166. PubMed ID: 36104679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
